Literature DB >> 14536086

mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression.

Hengbin Wang1, Woojin An, Ru Cao, Li Xia, Hediye Erdjument-Bromage, Bruno Chatton, Paul Tempst, Robert G Roeder, Yi Zhang.   

Abstract

Methylation of histone tails plays an important role in chromatin structure and function. Previously, we reported that ESET/SETDB1 is a histone methyltransferase (HMTase). Here, we show that SETDB1 tightly associates with the human homolog of mAM, a murine ATFa-associated factor. Although recombinant ESET can methylate lysine 9 of histone H3 (H3-K9), its activity is severely compromised when compared to that of the ESET/mAM complex. mAM stimulates ESET enzymatic activity by increasing the Vmax and decreasing the Km. Importantly, mAM facilitates the ESET-dependent conversion of dimethyl H3-K9 to the trimethyl state both in vitro and in vivo. Chromatin-based transcription and ChIP analyses demonstrate that mAM enhances ESET-mediated transcriptional repression in a SAM-dependent manner, and this repression correlates with H3-K9 trimethylation at the promoter. Thus, our studies establish that promoter H3-K9 trimethylation is the cause of transcriptional repression and that mAM/hAM facilitates conversion of H3-K9 dimethyl to trimethyl by ESET/SETDB1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14536086     DOI: 10.1016/j.molcel.2003.08.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  129 in total

Review 1.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

Review 2.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

Review 3.  Role of histone methylation and demethylation in adipogenesis and obesity.

Authors:  Masashi Okamura; Takeshi Inagaki; Toshiya Tanaka; Juro Sakai
Journal:  Organogenesis       Date:  2010 Jan-Mar       Impact factor: 2.500

4.  Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies.

Authors:  Sara Pagans; Naoki Sakane; Martina Schnölzer; Melanie Ott
Journal:  Methods       Date:  2010-07-06       Impact factor: 3.608

5.  Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates.

Authors:  Olivier Binda; Gary LeRoy; Dennis J Bua; Benjamin A Garcia; Or Gozani; Stéphane Richard
Journal:  Epigenetics       Date:  2010 Nov-Dec       Impact factor: 4.528

6.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

7.  Histone-lysine N-methyltransferase SETDB1 is required for development of the bovine blastocyst.

Authors:  Michael C Golding; Matthew Snyder; Gayle L Williamson; Kylee J Veazey; Michael Peoples; Jane H Pryor; Mark E Westhusin; Charles R Long
Journal:  Theriogenology       Date:  2015-07-29       Impact factor: 2.740

Review 8.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

9.  Functional analysis of histone methyltransferase g9a in B and T lymphocytes.

Authors:  Lance R Thomas; Hiroki Miyashita; Robin Milley Cobb; Steven Pierce; Makoto Tachibana; Elias Hobeika; Michael Reth; Yoichi Shinkai; Eugene M Oltz
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Jong-Yeon Shin; Won-Chul Lee; Jinhong Wie; Ki Yoon Kim; Min Young Lee; Daehee Hwang; Rajiv R Ratan; Ae Nim Pae; Neil W Kowall; Insuk So; Jong-Il Kim; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2013-03-02       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.